EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Value of holter monitoring in predicting arrhythmia recurrence on amiodarone



Value of holter monitoring in predicting arrhythmia recurrence on amiodarone



American Heart Association Monograph (107): II-437




(PDF emailed within 1 workday: $29.90)

Accession: 029528959

Download citation: RISBibTeXText



Related references

Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. American Journal of Cardiology 55(6): 709-712, 1985

Sustained monomorphic ventricular tachycardia treated with amiodarone value of holter monitoring and electrophysiologic study for predicting recurrence. European Heart Journal 10(ABSTR SUPPL): 165, 1989

Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone). Minerva Cardioangiologica 33(5): 251-258, 1985

The utility and early holter monitoring in predicting clinical efficacy of amiodarone in ventricular tachycardia. Journal of the American College of Cardiology 7(2 SUPPL A): 144A, 1986

Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease. American Journal of Cardiology 73(8): 554-558, 1994

Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy. Journal of the American College of Cardiology 6(4): 806-813, 1985

Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia. Journal of the American College of Cardiology 9(1): 169-174, 1987

Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia. Journal of the American College of Cardiology 9(2): 398-404, 1987

Clinical characteristics of ventricular arrhythmia in NIDDM: Evaluation of arrhythmia using Holter ECG monitoring. Journal of the Japan Diabetes Society 37(5): 349-355, 1994

Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone. Journal of the American College of Cardiology 7(4): 938-941, 1986

Utility and ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone. Journal of the American College of Cardiology 7(4): 938-941, 1986

Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia. Revista Portuguesa de Cardiologia 9(1): 33-39, 1990

Practical application of Holter ECG monitoring. Part I. Basic principles of the equipment of Holter ECG monitoring system. Indications for Holter monitoring. Kardiologiia 42(5): 85-91, 2002

Arrhythmia surveillance by transtelephonic monitoring: comparison with Holter monitoring in symptomatic ambulatory patients. American Heart Journal 98(4): 459-464, 1979